Anastrozole 1 mg Tablets (Anatero) – Oncology Export Supplier

Anastrozole 1 mg tablets, marketed under the brand name Anatero, is a prescription-only oral oncology medicine containing the active ingredient Anastrozole. It belongs to the class of aromatase inhibitors, used within regulated oncology treatment frameworks. This product is manufactured for professional healthcare supply chains and is offered strictly for international export to licensed pharmaceutical distributors, hospitals, and oncology care institutions. AmeriDrugs does not supply this product for retail or direct-to-patient sales.

Active Ingredient

• Anastrozole 1 mg tablets
  Anastrozole is a non-steroidal aromatase inhibitor that reduces estrogen synthesis and is utilized under approved oncology indications with medical supervision.

Therapeutic Use

From an informational and regulatory perspective, Anastrozole 1 mg tablets is used in approved oncology indications related to hormone-dependent breast cancer management, as defined by health authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment recommendations, or patient-level guidance.

Dosage Form

• Oral solid dosage form
• Film-coated tablets
• Supplied in unit-dose packaging suitable for hospital pharmacies and institutional use
• Administration and treatment decisions are determined exclusively by qualified oncology professionals in accordance with local regulations

Quality & Manufacturing Standards

Anastrozole 1 mg tablets (Anatero) are manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Manufacturing processes include raw material qualification, in-process quality controls, and finished product testing to ensure identity, strength, purity, and consistency aligned with international export requirements.

Packaging Information

• Pack size: 1 × 10 tablets
• Pharmaceutical-grade blister packaging
• Secure secondary packaging designed for international shipping and export logistics
• Labeling compliant with prescription oncology medicine regulations

Target Buyers

This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors
• Hospitals and oncology treatment centers
• Government and private cancer care institutions
• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note

Anastrozole Tablets IP 1 mg (Anatero) is a prescription-only oncology medicine. Importation, distribution, and use must comply with the pharmaceutical laws, drug authority approvals, and oncology regulations of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote this product for self-medication or any non-regulated applications.